Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cortes-Hernandez, J.
Right arrow Articles by Vilardell-Tarres, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cortes-Hernandez, J.
Right arrow Articles by Vilardell-Tarres, M.
Related Collections
Right arrow Pregnancy and Rheumatic Diseases
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2002; 41: 643-650
© 2002 British Society for Rheumatology

Original Papers

Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies

J. Cortés-Hernández, J. Ordi-Ros, F. Paredes, M. Casellas1, F. Castillo2 and M. Vilardell-Tarres

Departments of Internal Medicine,
1 Obstetrics and Gynaecology and
2 Paediatrics, Vall d'Hebron Hospitals, Barcelona, Spain

Objective. Our aim was to assess the outcome of pregnancy in a cohort of patients with SLE and to evaluate clinical and laboratory markers for fetal outcome and maternal flares.

Methods. Sixty patients with 103 pregnancies were evaluated prospectively between 1984 and 1999.

Results. There were 68 live births, 15 spontaneous abortions, 12 stillbirths and eight therapeutic abortions. Of liveborn infant births, 19 were premature, 24 had suffered intrauterine growth restriction and one had neonatal lupus. Maternal lupus flares occurred in 33% of pregnancies, mostly in the second trimester (26%) and in the post-partum period (51%). Flares during pregnancy showed a statistically significant association with discontinuation of chloroquine treatment, a history of more than three flares before gestation, and a SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) score of >=5 in these flares. Antiphospholipid antibodies, C3 hypocomplementaemia and hypertension during pregnancy were significantly associated with fetal loss, prematurity and intrauterine growth restriction.

Conclusions. Patients with more active SLE and those with aPL antibodies and hypertension should be monitored and managed carefully during pregnancy.

KEY WORDS: Systemic lupus erythematosus, Pregnancy, Fetal outcome, SLE flares, Antiphospholipid antibodies, Hypertension, Hypocomplementaemia.

Correspondence to: J. Ordi-Ros, Laboratori de Recerca de Medicina Interna 1, Hospital general Vall d'Hebron, Passeig Vall d'Hebron 119-129, E-08035 Barcelona, Spain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
F. Mecacci, B. Bianchi, A. Pieralli, B. Mangani, A. Moretti, R. Cioni, L. Giorgi, G. Mello, and M. Matucci-Cerinic
Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies
Rheumatology, March 1, 2009; 48(3): 246 - 249.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A. Leanos-Miranda, G. Cardenas-Mondragon, A. Ulloa-Aguirre, I. Isordia-Salas, A. Parra, and J. Ramirez-Peredo
Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome
Lupus, May 1, 2007; 16(5): 342 - 349.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
R. M. Andrade, G. McGwin Jr, G. S. Alarcon, M. L. Sanchez, A. M. Bertoli, M. Fernandez, B. J. Fessler, M. Apte, A. M. Arango, H. M. Bastian, et al.
Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII)
Rheumatology, November 1, 2006; 45(11): 1380 - 1384.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
Y Molad, T Borkowski, A Monselise, A Ben-Haroush, J Sulkes, M Hod, D Feldberg, and J Bar
Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies
Lupus, February 1, 2005; 14(2): 145 - 151.
[Abstract] [PDF]

Home page
 LupusHome page
G Moroni and C Ponticelli
Pregnancy after lupus nephritis
Lupus, January 1, 2005; 14(1): 89 - 94.
[Abstract] [PDF]

Home page
 LupusHome page
M Ostensen
Disease specific problems related to drug therapy in pregnancy
Lupus, September 1, 2004; 13(9): 746 - 750.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.